LVAD Patients' infection risks under the microscope
NCT ID NCT07255716
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at 120 adults getting a left ventricular assist device (LVAD) to see how often infections happen and how their immune system changes after surgery. The goal is to find what makes some patients more likely to get infections. This research does not test a new treatment but aims to improve future care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRIVELINE HEART-ASSISTED DEVICE RELATED INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fuwai Hospital
Beijing, Xicheng, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Could a gentler tug on the Heart's reins spark recovery?
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Can brain waves predict thinking problems after sepsis?
- Breathing technique may outperform spirometry for smog pneumonia recovery